New Zealand markets close in 5 hours 25 minutes

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
291.43+3.15 (+1.09%)
At close: 04:00PM EST
291.90 +0.47 (+0.16%)
After hours: 05:13PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 41.99B
Enterprise value 43.71B
Trailing P/E 14.90
Forward P/E 18.55
PEG ratio (5-yr expected) 32.54
Price/sales (ttm)4.12
Price/book (mrq)3.29
Enterprise value/revenue 4.22
Enterprise value/EBITDA 10.45

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 329.63%
S&P500 52-week change 3-9.08%
52-week high 3311.88
52-week low 3187.16
50-day moving average 3286.90
200-day moving average 3240.65

Share statistics

Avg vol (3-month) 31.2M
Avg vol (10-day) 3785.12k
Shares outstanding 5144M
Implied shares outstanding 6N/A
Float 8143.57M
% held by insiders 10.68%
% held by institutions 189.89%
Shares short (12 Jan 2023) 41.89M
Short ratio (12 Jan 2023) 41.58
Short % of float (12 Jan 2023) 41.48%
Short % of shares outstanding (12 Jan 2023) 41.31%
Shares short (prior month 14 Dec 2022) 42.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 27.64%
Operating margin (ttm)28.54%

Management effectiveness

Return on assets (ttm)7.60%
Return on equity (ttm)20.23%

Income statement

Revenue (ttm)10.36B
Revenue per share (ttm)70.97
Quarterly revenue growth (yoy)-9.70%
Gross profit (ttm)8.87B
Net income avi to common (ttm)2.86B
Diluted EPS (ttm)19.62
Quarterly earnings growth (yoy)244.70%

Balance sheet

Total cash (mrq)4.91B
Total cash per share (mrq)34.1
Total debt (mrq)6.63B
Total debt/equity (mrq)51.96
Current ratio (mrq)2.49
Book value per share (mrq)88.72

Cash flow statement

Operating cash flow (ttm)2.4B
Levered free cash flow (ttm)2.31B